藥品的品質攸關人民的健康安全，因此，政府近年來積極建構完善的藥品供應鏈體系，而全球化的趨勢導致藥品供應鏈分工越來越複雜，但為確保藥品品質，藥品管理應涵蓋藥品整的生命週期，近年來，政府積極爭取成為國際性的藥品組織以利於與世界接軌，而台灣正式於2013年1月1日起成為國際醫藥品稽查協約組織(The Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, PIC/S)成員後，不僅使台灣藥業品質再更上層樓外，在藥業稽核系統上，亦可受到國際間組織會員的認可，讓台灣向國際上更邁向一大步。　　
本研究為探討藥品優良運銷規範的實施，對於藥品供應鏈的成員其影響及相關因應策略為何，因此採用個案研究法訪談個案製劑藥廠以及物流協力廠，分析其雙方對於法規的實施影響(副作用)以及相關衝突，並模仿P.Z.B服務缺口模式，進一步分析顧客(製劑藥廠)與服務提供者(物流協力廠)兩者期望認知。
在本研究分析可知，其GDP法規的實施，物流協力廠需投入較大資源以滿足顧客需求，以提升本身競爭力，而製劑藥廠執行程度較物流協力廠為落實；而在模仿P.Z.B服務缺口模式下，期許物流協力廠能夠提供的服務與可達到期望服務是有落差的；最後，在GDP法規的實施，製劑藥廠與物流協力廠雙方主要衝突為價格調整、配送時間與模式以及法規執行度。

Recently, the issue of pharmaceutical supply chain has received increasing attention. Pharmaceutical quality plays a crucial role in addressing the issue of pharmaceutical product lifecycle management. (LCM) The purpose of this study investigates the impacts of implementing Good Distribution Practice (GDP) on the pharmaceutical supply chain members and the effects of applying the PZB Gap Service Quality Model developed by Parasuraman, Zeithaml and Berry (1985) on organizational conflicts of interest. Using a case study method, this paper applies the PZB Gap Model of Service Quality to analyze the impacts of organizational conflicts of interest and then to determine the coping strategies. Results from this study revealed that the major conflicts of implementing GDP regulations between pharmaceutical manufacturers and the logistics suppliers are: (a) price adjustment; (b) delivery time and model; and (c) the effective regulation of GDP. Based on these findings, this paper suggests that the logistics suppliers should invest much more funds in order to satisfy customer demand and to enhance its competitiveness.

英文部分：
Bazerman, M.H., Curhan, J.R., Moore,D.A., &Valley, K.L.(2000); Negotiation. Annual Review of Psychology, 51, pp. 279–314
Bishara, R. H. (2006). Cold chain management-an essential component of the global pharmaceutical supply chain. American Pharmaceutical Review, 9(1), 105-109.
Coombs, W. T. (1995). Choosing the right words the development of guidelines for the selection of the “appropriate” crisis-response strategies. Management Communication Quarterly, 8(4), 447-476.
Curhan, J. R., Elfenbein, H. A., & Xu, H. (2006). What do people value when they negotiate? Mapping the domain of subjective value in negotiation. Journal of personality and social psychology, 91(3), 493.
Jehn, K. A. (1995). A multimethod examination of the benefits and detriments of intragroup conflict. Administrative science quarterly, 256-282.
Kennedy, M. M. (1979). Generalizing from single case studies. Evaluation Review, 3(4), 661-678.
Lewicki, R., Saunders, D.,& Barry, B.( 2009) Negotiation,6th ed.(New York:McGraw-Hill/Irwin,2009)
Lipset, S. M., Trow, M. A., & Coleman, J. S. (2004). Union democracy: The internal politics of the International Typographical Union. The Case Study Anthropology, Thousand Oaks, CA: Sage, 113-124.
Liu, G., Li, Z., & Bo, S. (2013). Architecture of the Pharmaceutical Supply Chain Management System based on Internet of Things. Advances in Information Sciences and Service Sciences, 5(3), 632.
Parasuraman, A., Berry, L. L., & Zeithaml, V. A. (1991). Refinement and reassessment of the SERVQUAL scale. Journal of retailing, 67(4), 420.
Parasuraman, A., Zeithaml, V. A., & Berry, L. L. (1985). A conceptual model of service quality and its implications for future research. the Journal of Marketing, 41-50.
Parasuraman, A., Zeithaml, V. A., & Berry, L. L. (1985). Determinants of perceived service quality. the Journal of Marketing, 49(1), 48.
Parasuraman, A., Zeithaml, V. A., & Berry, L. L. (1985). A conceptual model of service quality and its implications for future research. the Journal of Marketing, 49(1), 44.
Parasuraman, A., Zeithaml, V. A., & Berry, L. L. (1988). Journal of Marketing, 52, 46.
Robbins, S. P. (1998). Fundamentos de comportamiento organizacional. Pearson education.
Ruble, T. L., & Thomas, K. W. (1976). Support for a two-dimensional model of conflict behavior. Organizational Behavior and Human Performance, 16(1), 143-155.
Shofuda, K. I., Aragane, K., Igari, Y., Matsumoto, K., and Ito, K. (2013). [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety]. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan, 134(2), 203-211.
Slabbert, A. D. (2004). Conflict management styles in traditional organisations. The Social Science Journal, 41(1), 83-92.
Thomas, K. (1976). Conflict and Conflict Management In Duneette (ed) Handbook of Industrial and Organisational Psychology.
Thomas, K. W. (1992). Conflict and negotiation processes in organizations. MD Dunnette & L. M. Hough (Ed.), Handbook of industrial and organizational psychology, Vol. 3: 651–717. Palo Alto.
Thomas, K. W. (1992). Conflict and conflict management: Reflections and update. Journal of organizational behavior, 13(3), 265-274.
Thomas, K. W., & Schmidt, W. H. (1976). A survey of managerial interests with respect to conflict. Academy of Management journal, 19(2), 315-318.
Yin, R. K. (2013). Case study research: Design and methods. Sage publications.
Zaffran, M., Vandelaer, J., Kristensen, D., Melgaard, B., Yadav, P., Antwi-Agyei, K. O., & Lasher, H. (2013). The imperative for stronger vaccine supply and logistics systems. Vaccine, 31, B73-B80.
Zeithaml, V. A., Berry, L. L., & Parasuraman, A. (1988). Communication and control processes in the delivery of service quality. The Journal of Marketing, 35-48.
Miller, W. L. , & Crabtree, B. F. (1992). Primary care research: A multimethod typology and qualitative road map. In B. F. Crabtree & W. L. Miller (Eds.), Doing qualitative research (pp. 3-28). Newbury Park, CA: Sage.
Strauss, A., & Corbin, J. (1990). Basics of qualitative research (Vol. 15). Newbury Park, CA: Sage.
Ericsson, K. A., & Simon, H. A. (1993). Protocol analysis. Cambridge, MA: MIT press.

中文部分：
胡政源. (2006). 品牌管理: 品牌價值的創造與經營. 新文京開發.
秦夢群. (2013). 教育領導理論與應用. 台灣五南圖書出版股份有限公司.
謝綺雯, (2015) .我國推動藥品優良運銷規範（GDP）管理制度與國際接軌之探討. 食品藥物研究年報, 6, 406 - 413.
黃琴吟(2011)，國內西藥廠GMP管理現況及未來展望，100年藥廠GMP國際化說明會。
衛福部食藥署(2015)，Guide to Good Distribution Practice for Medicinal Products PE011-1，衛福部食藥署
西藥GMP電子報 第R2期(2016) Retrieved from
http://www.fda.gov.tw/tc/siteListContent.aspx?sid=306&id=22114&chk=9f65d5bd-63ef-4df4-973b-017ba3cf594b#.WE5sjXZf3mI
衛福部食藥署(2016) Retrieved from http://www.fda.gov.tw/TC/siteListContent.aspx?sid=301&id=409&chk=f7ba5321-6a79-4527-b42f-9f9d985b13b1¶m=pn%3d2%26sid%3d301#.WBqkI3Zf3mI
藥物食品檢驗局(2008) Retrieved from http://www.nlfd.gov.tw/ShowModule.aspx?tab=421&mtab=DOC&act=Detail&docid=1864